REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
26/05/2025
Voltar para busca
Dado oficial do USPTO
HAISCO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
27/05/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10, 35
Data de depósito
24/05/2019
Data de registro
26/05/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/05/2020
Última transação
27/05/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
CN
Examinador
BRADLEY, EVELYN
Unidade examinadora
L40
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording "HAISCO" with a polygon with curved sides.
Titulares e representantes
Titulares
Haisco Pharmaceutical Group Co., Ltd.
HAISCO PHARMACEUTICAL GROUP CO.
Representantes
Willy H. Wong Minder Law Group
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 35
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medicines for human purposesspecifically for the treating or prevention of hepatopathyneoplasmcancertumorsneurologic disordersdigestive and cardiovascular diseasesinfectionsendocrine disorderseye disordersmetabolic disordersAIDSdermatological disorderspsychiatric disorderselectrolyte imbalancerespiratory disorderspainimmunological diseasesfor use in surgery; biological preparation for medical purposesspecifically for the treatment of hepatopathyneoplasmcancertumorsneurologic disordersdigestive and cardiovascular diseasesinfectionsendocrine disorderseye disordersmetabolic disordersAIDSdermatological disorderspsychiatric disorderselectrolyte imbalancerespiratory disorderspainimmunological diseasesfor use in surgery; pharmaceutical preparation for treating hepatopathyneoplasmcancertumorsneurologic disordersdigestive and cardiovascular diseasesinfectionsendocrine disorderseye disordersmetabolic disordersAIDSdermatological disorderspsychiatric disorderselectrolyte imbalancerespiratory disorderspainimmunological diseasesfor use in surgery; chemico-pharmaceutical preparations; chemical preparations for medical purposesfor treating hepatopathyneoplasmcancertumorsneurologic disordersdigestive and cardiovascular diseasesinfectionsendocrine disorderseye disordersmetabolic disordersAIDSdermatological disorderspsychiatric disorderselectrolyte imbalancerespiratory disorderspainimmunological diseasesfor use in surgery; prepared Chinese medicineherbal extracts for the treatment of hepatopathyneoplasmcancertumorsneurologic disordersdigestive and cardiovascular diseasesinfectionsendocrine disorderseye disordersmetabolic disordersAIDSdermatological disorderspsychiatric disorderselectrolyte imbalancerespiratory disorderspainimmunological diseasesfor use in surgery; biomedicine preparations for the treatment of hepatopathyneoplasmcancertumoursneurologic disordersdigestive and cardiovascular diseasesinfectionsendocrine disorderseye disordersmetabolic disordersAIDSdermatological disorderspsychiatric disorderselectrolyte imbalancerespiratory disorderspainimmunological diseases and for use in surgery; medicated candy; albuminous foodstuffs being dietetic foods adapted for medical purposes
Classe 10
Medical apparatus and instruments for use in surgery; diagnostic apparatus for medical purposesspecifically for the detection of heart diseases; gastroscopes; mirrors for surgeons; testing apparatus for medical purposesapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing; endoscopy cameras for medical purposes; surgical apparatus and instruments; suture materials; cooling patches for medical purposes; surgical implants comprised of artificial materials
Classe 35
Retail store services featuring pharmaceuticalveterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceuticalsveterinary and sanitary preparations and medical supplies; search engine optimization for sales promotion; retail store or wholesale store services for featuring pharmaceuticals
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/04/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/04/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/04/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/01/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/01/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/01/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
18/10/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
26/09/2020
FIMP
FINAL DISPOSITION PROCESSED
25/09/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
26/08/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
16/07/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
26/05/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/03/2020
PUBO
PUBLISHED FOR OPPOSITION
10/03/2020
GPNX
NOTIFICATION PROCESSED BY IB
07/03/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
19/02/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
19/02/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/02/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/02/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/12/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
19/12/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
21/11/2019
GNFR
FINAL REFUSAL E-MAILED
21/11/2019
CNFR
FINAL REFUSAL WRITTEN
21/11/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/10/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/10/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/10/2019
RFNT
REFUSAL PROCESSED BY IB
13/09/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
26/08/2019
RFRR
REFUSAL PROCESSED BY MPU
26/08/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/08/2019
CNRT
NON-FINAL ACTION WRITTEN
03/08/2019
DOCK
ASSIGNED TO EXAMINER
31/07/2019
MAFR
APPLICATION FILING RECEIPT MAILED
19/07/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/07/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/07/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HAISCO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.